| Literature DB >> 26442040 |
Xuepeng Fu1, Xia Wu2, Xingang Zhou3, Shouwei Liu3, Yanhui Shen3, Fengzhi Wu3.
Abstract
Intercropping could alleviate soil-borne diseases, however, few studies focused on the immunity of the host plant induced by the interspecific interactions. To test whether or not intercropping could enhance the disease resistance of host plant, we investigated the effect of companion cropping with potato onion on tomato Verticillium wilt caused by Verticillium dahliae (V. dahliae). To investigate the mechanisms, the root exudates were collected from tomato and potato onion which were grown together or separately, and were used to examine the antifungal activities against V. dahliae in vitro, respectively. Furthermore, RNA-seq was used to examine the expression pattern of genes related to disease resistance in tomato companied with potato onion compared to that in tomato grown alone, under the condition of infection with V. dahliae. The results showed that companion cropping with potato onion could alleviate the incidence and severity of tomato Verticillium wilt. The further studies revealed that the root exudates from tomato companied with potato onion significantly inhibited the mycelia growth and spore germination of V. dahliae. However, there were no significant effects on these two measurements for the root exudates from potato onion grown alone or from potato onion grown with tomato. RNA-seq data analysis showed the disease defense genes associated with pathogenesis-related proteins, biosynthesis of lignin, hormone metabolism and signal transduction were expressed much higher in the tomato companied with potato onion than those in the tomato grown alone, which indicated that these defense genes play important roles in tomato against V. dahliae infection, and meant that the disease resistance of tomato against V. dahliae was enhanced in the companion copping with potato onion. We proposed that companion cropping with potato onion could enhance the disease resistance of tomato against V. dahliae by regulating the expression of genes related to disease resistance response. This may be a potential mechanism for the management of soil-borne plant diseases in the intercropping system.Entities:
Keywords: RNA-seq; Verticillium dahliae; companion cropping; disease resistance; interspecific interaction; root exudates; soil-borne diseases
Year: 2015 PMID: 26442040 PMCID: PMC4566073 DOI: 10.3389/fpls.2015.00726
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Disease incidence and disease symptoms score of tomato inoculated with Vd1. (A,B) Disease incidence of tomato in 2013 and 2014, respectively. (C,D) Disease symptoms score in 2013 and 2014, respectively. 18 DAI and 28 DAT indicate 18 and 28 days after infected by Vd1, respectively. Data were the means of three replicates with standards errors shown by vertical bars. The different small letters above the bars represent the significance between two groups of mean values at a lever of p = 0.05 according to independent sample t-test.
Figure 2Effect of root exudates on the mycelia growth and spore germination of Vd1. (A) Effect of root exudates from tomatoes on Vd1 mycelia growth (colony diameter). (B) Effect of root exudates from potato onions on Vd1 mycelia growth (colony diameter). (C) Effect of root exudates from tomatoes and potato onions on Vd1 mycelia growth (colony diameter) at a concentration of 1 gFW·10 mL−1. (D) Effect of root exudates from tomatoes and potato onions on Vd1 spore germination at a concentration of 1 g FW·10 mL−1. Data are the means of five replicates with standards errors shown by vertical bars. The different small letters above the bars represent among different groups according to Tukey's tests at p = 0.05 level.
Alignment statistics result with reference genome for all samples.
| TC1 | 12173342 | 596493758 | 10419039 (85.59%) | 8842098 (72.63%) | 1576941 (12.95%) | 10026087 (82.36%) | 392952 (3.23%) | 1754303 (14.41%) |
| TC2 | 12175372 | 596593228 | 10291852 (84.53%) | 8683647 (71.32%) | 1608205 (13.21%) | 9910113 (81.39%) | 381739 (3.14%) | 1883520 (15.47%) |
| TC3 | 12175309 | 596590141 | 10280870 (84.44%) | 8671568 (71.22%) | 1609302 (13.22%) | 9888545 (81.22%) | 392325 (3.22%) | 1894439 (15.56%) |
| TM1 | 12172555 | 596455195 | 10479406 (86.09%) | 9031982 (74.20%) | 1447424 (11.89%) | 10118908 (83.13%) | 360498 (2.96%) | 1693149 (13.91%) |
| TM2 | 12165484 | 596108716 | 10357756 (85.14%) | 8719061 (71.67%) | 1638695 (13.47%) | 9885908 (81.26%) | 471848 (3.88%) | 1807728 (14.86%) |
| TM3 | 12175211 | 596585339 | 10470208 (86.00%) | 8843302 (72.63%) | 1626906 (13.36%) | 10065455 (82.67%) | 404753 (3.32%) | 1705003 (14.00%) |
Indicates percentages in total reads.
Figure 3Gene expression level in TC compared to TM.
Figure 4GO Functional Classification of DEGs.
Top 20 enriched KEGG pathways.
| Metabolic pathways | 70 (33.18% | ko01100 |
| Biosynthesis of secondary metabolites | 54 (25.59%) | ko01110 |
| Zeatin biosynthesis | 18 (8.53%) | ko00908 |
| Phenylpropanoid biosynthesis | 18 (8.53%) | ko00940 |
| Glutathione metabolism | 17 (8.06%) | ko00480 |
| Plant hormone signal transduction | 17 (8.06%) | ko04075 |
| Phenylalanine metabolism | 10 (4.74%) | ko00360 |
| Plant-pathogen interaction | 10 (4.74%) | ko04626 |
| Flavone and flavonol biosynthesis | 9 (4.27%) | ko00944 |
| Flavonoid biosynthesis | 9 (4.27%) | ko00941 |
| Cysteine and methionine metabolism | 8 (3.79%) | ko00270 |
| Starch and sucrose metabolism | 8 (3.79%) | ko00500 |
| Stilbenoid, diarylheptanoid and gingerol biosynthesis | 7 (3.32%) | ko00945 |
| Benzoxazinoid biosynthesis | 6 (2.84%) | ko00402 |
| Oxidative phosphorylation | 6 (2.84%) | ko00190 |
| Cyanoamino acid metabolism | 5 (2.37%) | ko00460 |
| Cutin, suberine, and wax biosynthesis | 5 (2.37%) | ko00073 |
| Ascorbate and aldarate metabolism | 5 (2.37%) | ko00053 |
| Carotenoid biosynthesis | 5 (2.37%) | ko00906 |
| ABC transporters | 5 (2.37%) | ko02010 |
Indicates the percentage of the total DEGs.
Expression patterns of DEGs related to biosynthesis of lignin.
| Solyc03g071870.1.1 | 20.49 | 0.844008772 | Phenylalanine ammonia-lyase |
| Solyc10g011920.1.1 | 5.99 | 0.863015339 | Phenylalanine ammonia-lyase |
| Solyc10g011930.1.1 | 10.15 | 0.906945967 | Phenylalanine ammonia-lyase |
| Solyc00g282510.1.1 | 7.30 | 0.898564424 | Phenylalanine ammonia-lyase |
| Solyc09g007910.2.1 | 3.38 | 0.814515824 | Phenylalanine ammonia-lyase |
| Solyc05g047530.2.1 | 5.34 | 0.810640148 | Trans-cinnamate 4-monooxygenase |
| Solyc00g247300.2.1 | 2.97 | 0.831442762 | Ferulate-5-hydroxylase |
| Solyc06g035960.2.1 | 6.41 | 0.873035379 | 4-coumarate-CoA ligase-like protein |
| Solyc03g097500.2.1 | 5.37 | 0.863885003 | Hydroxycinnamoyl CoA shikimate |
| Solyc03g097500.2.1 | 8.04 | 0.886628603 | Hydroxycinnamoyl transferase |
| Solyc04g078660.1.1 | 3.39 | 0.822122232 | Hydroxycinnamoyl transferase |
| Solyc01g107080.2.1 | 22.22 | 0.897934233 | Laccase |
| Solyc04g072280.2.1 | 4.18 | 0.800374334 | Laccase |
| Solyc06g050530.2.1 | 2.56 | 0.800078144 | Laccase 1a |
| Solyc04g054690.2.1 | 2.69 | 0.810375468 | Laccase-13 |
| Solyc06g082240.2.1 | 0.40 | 0.818530142 | Peroxidase |
| Solyc06g082420.2.1 | 7.75 | 0.864389156 | Peroxidase 3 |
| Solyc02g087070.2.1 | 3.82 | 0.829369431 | Peroxidase family protein |
Probability ≥ 0.8 and absolute value of Ratio ≥ 2 as the threshold to judge the significance of gene expression difference. FPKM represents the expression level.
Expression patterns of DEGs related to disease defense.
| Solyc10g079860.1.1 | 4.22 | 0.813205026 | Beta-1 3-glucanase |
| Solyc10g055800.1.1 | 2.23 | 0.800084446 | Chitinase |
| Solyc02g082920.2.1 | 6.96 | 0.877333283 | Endochitinase |
| Solyc05g054380.1.1 | 11.08 | 0.833408956 | Pathogenesis-related protein STH-2-like |
| Solyc08g080670.1.1 | 2.86 | 0.826678514 | PR5-like protein precursor |
| Solyc02g065470.1.1 | 3.77 | 0.841506913 | Pathogenesis-related protein |
| Solyc00g174340.1.1 | 2.50 | 0.817578553 | Pathogenesis-related protein 1b |
| Solyc07g006700.1.1 | 14.86 | 0.895180298 | Pathogenesis-related protein PR-1 |
| Solyc10g081980.1.1 | 2.53 | 0.804735257 | Harpin-induced protein-like |
| Solyc02g036480.1.1 | 6.59 | 0.881316091 | Harpin-induced protein-like |
| Solyc03g098730.1.1 | 4.96 | 0.826401231 | Kunitz trypsin inhibitor ST1-like |
| Solyc03g098740.1.1 | 10.90 | 0.902559837 | Kunitz trypsin inhibitor |
| Solyc03g019690.1.1 | 12.28 | 0.853587679 | Kunitz-type protease inhibitor |
| Solyc03g020010.1.1 | 5.01 | 0.870766691 | Kunitz-type trypsin inhibitor alpha chain |
| Solyc09g082300.2.1 | 5.79 | 0.819311579 | Non-specific lipid-transfer protein |
| Solyc09g065440.2.1 | 4.88 | 0.837675351 | Non-specific lipid-transfer protein |
| Solyc09g065430.2.1 | 3.31 | 0.845225041 | Non-specific lipid-transfer protein |
| Solyc01g005990.2.1 | 4.51 | 0.854652702 | Non-specific lipid-transfer protein |
| Solyc08g067500.1.1 | 0.37 | 0.833383749 | Non-specific lipid-transfer protein |
| Solyc03g005210.2.1 | 2.98 | 0.815738395 | Non-specific lipid-transfer protein |
| Solyc01g103060.2.1 | 3.32 | 0.822323893 | Non-specific lipid-transfer protein |
| Solyc09g082270.2.1 | 3.58 | 0.858074643 | Non-specific lipid-transfer protein |
| Solyc01g081600.2.1 | 3.03 | 0.831764157 | Non-specific lipid-transfer protein |
| Solyc10g075100.1.1 | 8.67 | 0.899156804 | Non-specific lipid-transfer protein |
| Solyc08g062220.2.1 | 5.94 | 0.843693677 | UDP-glucose glucosyltransferase |
| Solyc08g006330.2.1 | 2.93 | 0.800727241 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc11g007390.1.1 | 9.35 | 0.878417212 | UDP-glucosyltransferase |
| Solyc11g007490.1.1 | 5.85 | 0.875783013 | UDP-glucosyltransferase |
| Solyc01g095620.2.1 | 2.92 | 0.836320442 | UDP-glucosyltransferase |
| Solyc11g007500.1.1 | 4.94 | 0.884372519 | UDP-glucosyltransferase |
| Solyc07g043150.1.1 | 3.90 | 0.859505174 | UDP-glucosyltransferase |
| Solyc02g085660.1.1 | 8.89 | 0.882551266 | UDP-glucosyltransferase |
| Solyc12g042600.1.1 | 5.92 | 0.888733442 | UDP-glucosyltransferase family 1 protein |
| Solyc01g107780.2.1 | 3.60 | 0.858534679 | UDP-glucosyltransferase family 1 protein |
| Solyc01g107820.2.1 | 4.15 | 0.877043395 | UDP-glucosyltransferase family 1 protein |
| Solyc10g079930.1.1 | 3.58 | 0.853965793 | UDP-glucosyltransferase HvUGT5876 |
| Solyc07g006800.1.1 | 4.62 | 0.869689064 | UDP-glucosyltransferase HvUGT5876 |
| Solyc12g057080.1.1 | 3.82 | 0.831505779 | UDP-glucuronosyltransferase |
| Solyc12g057060.1.1 | 3.01 | 0.848394903 | UDP-glucuronosyltransferase |
| Solyc03g078490.2.1 | 6.36 | 0.845697685 | UDP-glucuronosyltransferase |
| Solyc03g071850.1.1 | 3.47 | 0.854173756 | UDP-glucuronosyltransferase 1-6 |
| Solyc12g009930.1.1 | 2.69 | 0.8174021 | UDP-glucuronosyltransferase 1-6 |
| Solyc10g085890.1.1 | 4.03 | 0.805838091 | UDP-glycosyltransferase 73C3-like |
| Solyc01g100090.1.1 | 127.98/0.01 | 0.988511614 | Wall-associated receptor kinase-like 20 |
| Solyc01g080010.2.1 | 4.91 | 0.861257105 | Xylanase inhibitor (Fragment) |
Probability ≥ 0.8 and the absolute value of Ratio (TC/TM) ≥ 2 as the threshold to judge the significance of gene expression difference. FPKM represents the expression level.
Indicates the gene was expressed only in TC (when the value of either sample FPKM was zero, 0.01 was used to instead of 0 to calculate the fold change).
Expression patterns of DEGs related to hormone metabolism and transcription factors.
| Solycg049530.2.1 | 5.60 | 0.832236801 | 1-aminocyclopropane-1-carboxylate oxidase |
| Solycg026650.2.1 | 15.26 | 0.819387202 | 1-aminocyclopropane-1-carboxylate oxidase |
| Solyc12g006380.1.1 | 6.18 | 0.891739454 | 1-aminocyclopropane-1-carboxylate oxidase-like protein |
| Solyc09g089580.2.1 | 5.88 | 0.826911685 | 1-aminocyclopropane-1-carboxylate oxidase-like protein |
| Solyc04g009860.2.1 | 3.05 | 0.822418422 | 1-aminocyclopropane-1-carboxylate oxidase-like protein |
| Solyc01g095080.2.1 | 13.46 | 0.894367351 | 1-aminocyclopropane-1-carboxylate synthase |
| Solyc06g053710.2.1 | 4.65 | 0.831587704 | Ethylene receptor |
| Solyc08g014000.2.1 | 0.42 | 0.804476878 | Lipoxygenase |
| Solyc08g029000.2.1 | 3.90 | 0.824378316 | Lipoxygenase |
| Solyc03g122340.2.1 | 4.12 | 0.810173807 | Lipoxygenase |
| Solyc12g013620.1.1 | 4.87 | 0.874434403 | NAC domain protein IPR003441(jasmonic acid 2) |
| Solyc03g071870.1.1 | 20.49 | 0.844008772 | Phenylalanine ammonia-lyase |
| Solyc10g011920.1.1 | 5.99 | 0.863015339 | Phenylalanine ammonia-lyase |
| Solyc10g011930.1.1 | 10.15 | 0.906945967 | Phenylalanine ammonia-lyase |
| Solyc00g282510.1.1 | 7.30 | 0.898564424 | Phenylalanine ammonia-lyase |
| Solyc09g007910.2.1 | 3.38 | 0.814515824 | Phenylalanine ammonia-lyase |
| Solyc08g062220.2.1 | 5.94 | 0.843693677 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc08g006330.2.1 | 2.93 | 0.800727241 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc11g007490.1.1 | 5.85 | 0.875783013 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc11g007500.1.1 | 4.94 | 0.884372519 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc03g078490.2.1 | 6.36 | 0.845697685 | UDP-glucose salicylic acid glucosyltransferase |
| Solyc09g005610.2.1 | 9.00 | 0.886849170 | BZIP transcription factor TGA2-like |
| Solyc02g080890.2.1 | 3.09 | 0.829923999 | Transcription factor WRKY31 isoform X1) |
| Solyc02g094270.1.1 | 4.05 | 0.817843234 | WRKY transcription factor 45 |
| Solyc06g066370.2.1 | 2.68 | 0.817320175 | WRKY transcription factor 1 |
| Solycg05g015850.2.1 | 6.76 | 0.846970671 | WRKY transcription factor-b |
| Solyc09g014990.2.1 | 3.13 | 0.803871895 | WRKY-like transcription factor 26 |
| Solyc09g089930.1.1 | 4.32 | 0.816948362 | Ethylene responsive transcription factor 1a |
| Solyc12g056590.1.1 | 3.80 | 0.816948362 | Ethylene responsive transcription factor 2a |
| Solyc04g071770.2.1 | 4.32 | 0.833591712 | Ethylene responsive transcription factor 2a |
| Solyc09g075420.2.1 | 4.61 | 0.864439571 | Ethylene responsive transcription factor 2b |
| Solyc09g091950.1.1 | 0.34 | 0.875776711 | Ethylene-responsive transcription factor 1 |
| Solyc02g077370.1.1 | 3.75 | 0.810993055 | Ethylene-responsive transcription factor 2 |
| Solyc01g104740.2.1 | 6.49 | 0.887132756 | Ethylene-responsive transcriptional coactivator |
| Solyc10g008700.1.1 | 6.47 | 0.818990182 | MYB transcription factor |
| Solyc09g090790.2.1 | 4.79 | 0.848502036 | MYB transcription factor |
| Solyc12g099130.1.1 | 6.62 | 0.807974439 | MYB transcription factor |
| Solyc02g089190.1.1 | 8.78 | 0.822746121 | MYB transcription factor |
| Solyc03g093890.2.1 | 4.18 | 0.826130248 | Myb-related transcription factor |
| Solyc02g089190.1.1 | 3.13 | 0.817843234 | Susceptibility homeodomain transcription factor |
| Solyc03g093890.2.1 | 4.00 | 0.830094151 | Sigma factor binding protein 1 |
| Solycg05g054650.1.1 | 4.09 | 0.821567664 | Zinc finger transcription factor ZFP19 |
| Solyc01g096510.2.1 | 2.67 | 0.817206741 | Zinc finger AN1 domain-containing stress-associated protein |
| Solyc02g087210.2.1 | 4.30 | 0.876198939 | Zinc finger family protein C2H2-type) |
| Solycg05g054650.1.1 | 4.09 | 0.821567664 | Zinc finger transcription factor ZFP19 |
Probability ≥ 0.8 and the absolute value of Ratio ≥ 2 as the threshold to judge the significance of gene expression difference. FPKM represents the expression level.